Recombinant adeno-associated viral vectors (rAAVs) are among the most commonly used vehicles for in vivo based gene therapies. However, it is hard to predict which AAV capsid will provide the most rob
Fab1-4 in complex with the capsid of Adeno-associated virus type 9 Descriptor: Capsid protein VP1, Fab1-4 heavy chain, Fab1-4 light chain Authors: Mietzsch, M, McKenna, R. Deposit date: 2024-03-25 Rel
Nucleic acid delivery carriers for gene therapy are of high interest, however barriers along the delivery system route can be deemed the culprit to low efficiency. In an attempt to achieve more effici
AAV8 human HEK293-produced, empty capsid Descriptor: Capsid protein Authors: Paulk, N.K, Poweleit, N. Deposit date: 2019-08-18 Release date: 2020-06-03 Last modified: 2024-03-20 Method: ELECTRON MICRO
We performed absolute quantification (AQUA) of viral proteins by targeted quantitative proteomics and conducted tandem mass tag (TMT)-based proteomics on the three rAAV and wtAAV production systems to